Clobazam for treatment of epilepsy

Bibliography

• Campos-Castello J. Lennox–Gastuat syndrome. Orphanet Encyclopedia. September 2004. Available from: http://www.orpha.net/data/patho/GB/uk-Lennox.pdf [Last accessed December 28, 2011]
   Google Scholar
• Cavazzuti GB. Epidemiology of different types of epilepsy in school age children of Modena, Italy. Epilepsia 1980;13:57-62
   Google Scholar
• Sidenvall R, Forsgren L, Heijbel J. Prevalence and characteristics of epilepsy in children in northern Sweden. Seizure 1996;5:139-46
   PubMedGoogle Scholar
• Trevathan E, Murphy CC, Yeargin-Allsopp M. Prevalence and descriptive epidemiology of Lennox–Gastaut syndrome among Atlanta children. Epilepsia 1997;38:1283-8
   PubMedGoogle Scholar
• Markand ON. Lennox–Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 2003;20:426-41
   PubMed Web of Science ®Google Scholar
• Arzimanoglou A, Guerrini R, Aicardi J. Epilepsies with predominantly myoclonic seizures. In: Aicardi's Epilepsy in Children. 3rd edition. Lippincott Williams & Wilkins; Philadelphia: 2004. p. 58-80
   Google Scholar
• Rober J, Dravet C, Bureau M. The Lennox–Gastaut syndrome. Cleve Clin J Med 1989;56(Suppl Pt 2):S172-80
   Google Scholar
• Arzimanoglou A, French J, Blume WT, Lennox–Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009;8:82-93
   PubMed Web of Science ®Google Scholar
• Arzimanoglou A, Resnick T. All children who experience epileptic falls do not necessarily have Lennox–Gastaut syndrome … but many do. Epileptic Disord 2011;13(Suppl 1):S3-11
   Google Scholar
• Glauser TA. Lennox-Gastaut syndrome. Emedicine http://emedicine.medscape.com/article/1176735-overview. [Last accessed 28 December 2011]
   Google Scholar
• Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998;39(Suppl 3):S2-10
   PubMed Web of Science ®Google Scholar
• Genton P, Guerrini R, Dravet C. The Lennox–Gastaut syndrome. In: Meinardi H, editor. Handbook of clinical neurology. The epilepsies, part II. 73 (29) Elsevier; Amsterdam: 2000. p. 211-22
   Google Scholar
• Berg AT, Berkovic SF, Brodie MJ, Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005 – 2009. Epilepsia 2010;51:676-85
   PubMed Web of Science ®Google Scholar
• Conry JA, Ng Y, Paolicchi JM, Clobazam in the treatment of Lennox–Gastaut syndrome. Epilepsia 2009;50:1158-66
   PubMed Web of Science ®Google Scholar
• Schmidt D, Bourgeois B. A risk-benefit assessment of therapies for Lennox–Gastaut syndrome. Drug Saf 2000;22:467-77
   PubMed Web of Science ®Google Scholar
• Chu-Shore CJ, Thiele EA. New drugs for pediatric epilepsy. Semin Pediatr Neurol 2010;17:214-23
   PubMed Web of Science ®Google Scholar
• Mills JK, Lewis TG, Mughal K, Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1 year. Seizure 2011;20:402-5
   PubMedGoogle Scholar
• Robertson MM. Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of Clobazam. Epilepsia 1986(Suppl 1)27:S27-41
   PubMedGoogle Scholar
• Ng Y, Collins S. Clobazam. Neurotherapeutics 2007;4:138-44
   PubMed Web of Science ®Google Scholar
• Wildin JD, Pleuvry BJ, Mawer GE, Respiratory and sedative effects of clobazam and clonazepam in volunteers. Br J Clin Pharmacol 1990;29:169-77
   PubMedGoogle Scholar
• Hindmarch I, Haller J, Sherwood N, Kerr JS. Comparison of five anxiolytic benzodiazepines on measures of psychomotor performance and sleep. Neuropsychobiology 1990/91;24:84-9
   PubMedGoogle Scholar
• Hanks GW. Clobazam: pharmacological and therapeutic profile. Br J Clin Pharmacol 1979;7:151S-15
   PubMed Web of Science ®Google Scholar
• Mohler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002;300:2-8
   PubMed Web of Science ®Google Scholar
• Doi T, Ueda Y, Tokumaru J, Willmore LJ. Molecular regulation of glutamate and GABA transporter proteins by clobazam during eliptogenesis in Fe(+++)-induced epileptic rats. Brain Res Mel Brain Res 2005; 142: 91-96
   PubMedGoogle Scholar
• McKernan RM, Rosahl TW, Reynolds DS, Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 2000;3:587-592
   PubMed Web of Science ®Google Scholar
• Clobazam In: DRUGDEX® System. Version 2.0. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc.
   Google Scholar
• Dichter MA and Brodie MJ. New Antiepileptic Drugs. NEJM 1996;334(24):1583-1590
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Ikeda A, Begum T, Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. Journal of the Neurological Sciences 2007;263:44-48
   PubMedGoogle Scholar
• Fielding S, Hoffmann I. Pharmacology of Anti-Anxiety Drugs with Special Reference to Clobazam. Br J Clin Pharmac 1979;7:7S-15S
   PubMedGoogle Scholar
• Tedeschi G, Riva R, Baruzzi A: Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients. Br J Clin Pharmac 1981;11:619-622
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Puri SK Clobazam Kinetics in the Elderly. Br J Clin Pharmac 1981;12:631-36
   PubMed Web of Science ®Google Scholar
• Canadian Clobazam Cooperative Group. Clobazam in treatment of refractory epilepsy: the Canadian experience. A Retrospective Study. Epilepsia 1991;32:407-16
   Google Scholar
• Ng Y, Conry JA, Drummond R, Stolle J, Weinberg MA. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011;77:1473-1481
   PubMed Web of Science ®Google Scholar
• Kalra V, Seth R, Mishra D and Saha N. Clobazam in Refractory Childhood Epilepsy. Indian Journal of Pediatrics 2010;77(3):263-266
   PubMed Web of Science ®Google Scholar
• Keene DL, Whiting S, Humphreys P. Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood. Can J Neurol Sci 1990;17:317-319
   PubMed Web of Science ®Google Scholar
• Montenegro MA, Arif H, Nabm E Efficacy of Clobazam as Add-on Therapy for Refractory Epilepsy: Experience at a US Epilepsy Center. Clin Neuropharmacol 2008;31:333-38
   PubMedGoogle Scholar
• Onfi®[package insert]. Deerfield, IL: Lundbeck, 2011
   Google Scholar